Liang, X., Xu, G., Zhang, J., Xu, L., Dong, L., Wang, X., . . . Chen, E. (2025). Combination chemotherapy with sintilimab for treatment of a male patient with primary pulmonary choriocarcinoma. Frontiers in Immunology, 16, . https://doi.org/10.3389/fimmu.2025.1523316
Chicago-referens (17:e uppl.)Liang, Xiaojing, Guoqing Xu, Jisong Zhang, Li Xu, Liangliang Dong, Xiaoyue Wang, Weidong Han, och Enguo Chen. "Combination Chemotherapy with Sintilimab for Treatment of a Male Patient with Primary Pulmonary Choriocarcinoma." Frontiers in Immunology 16 (2025). https://doi.org/10.3389/fimmu.2025.1523316.
MLA-referens (9:e uppl.)Liang, Xiaojing, et al. "Combination Chemotherapy with Sintilimab for Treatment of a Male Patient with Primary Pulmonary Choriocarcinoma." Frontiers in Immunology, vol. 16, 2025, https://doi.org/10.3389/fimmu.2025.1523316.
